<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-180 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-180</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-180</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <p><strong>Paper ID:</strong> paper-0d4643215fa9099ee9de8eb9b948730d3e54c385</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/0d4643215fa9099ee9de8eb9b948730d3e54c385" target="_blank">Evaluation of the poly(ADP‐ribose) polymerase‐1 gene variants in Alzheimer's disease</a></p>
                <p><strong>Paper Venue:</strong> Journal of clinical laboratory analysis (Print)</p>
                <p><strong>Paper TL;DR:</strong> Results reveal that the PARP‐1 gene is highly associated with AD susceptibility and might contribute to a critical mechanism that mediates cell survival or death as a response to cytotoxic stress.</p>
                <p><strong>Cost:</strong> 0.009</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e180.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e180.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Neurons (hippocampus & cortex)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurons in hippocampal and cerebral cortical regions</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Principal CNS neurons in the hippocampus and cerebral cortex, reported in this paper as undergoing irreversible loss in Alzheimer's disease and showing molecular signs of stress linked to PARP-1 activation.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Evaluation of the Poly(ADP-ribose) Polymerase-1 Gene Variants in Alzheimer's Disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>neurons (hippocampal and cortical)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Clinical observation of irreversible neuronal loss in hippocampus and cerebral cortex in AD patients; immunohistochemical detection of PARP-1 overactivation and increased poly(ADP-ribosyl)ation in brain sections from AD patients; experimental models (transgenic mice, rat hippocampus) show Aβ accumulation correlates with oxidative stress and impaired neuronal survival.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Aβ accumulation → increased ROS/oxidative stress and DNA strand breaks → NMDA receptor-mediated excitotoxicity (excess Ca2+ influx) and nitric oxide/peroxynitrite production → activation/overactivation of PARP-1 → excessive poly(ADP-ribosyl)ation, NAD+ depletion and downstream cell-death signaling (including PARP-1-dependent mechanisms such as AIF-mediated death); additionally, PARP-1 genetic variants (e.g., Val762Ala) may modulate PARP-1 enzymatic activity and thereby influence neuronal susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human AD brain sections (immunohistochemistry cited), transgenic mouse models of Aβ accumulation, and adult rat hippocampus experiments cited in the paper.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>described in context of late/age-dependent neurodegeneration (late-onset AD / advanced neuronal loss); stage not precisely stratified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>No contradictory findings regarding neuronal susceptibility are reported within this paper.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e180.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e180.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PBMCs</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Peripheral blood mononuclear cells</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Peripheral immune cells (monocytes/lymphocytes) from blood that are reported in the paper to show increased PARP-1 protein levels and poly(ADP-ribosyl)ation in AD patients compared with healthy subjects.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Evaluation of the Poly(ADP-ribose) Polymerase-1 Gene Variants in Alzheimer's Disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>peripheral blood mononuclear cells (PBMCs)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>unclear</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Cited observations of accumulated PARP-1 protein and increased poly(ADP-ribose) modification in PBMCs from AD patients versus controls (references 13, 29, 30), indicating systemic markers of PARP-1 activation but not direct demonstration of susceptibility to AD neuropathology.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Systemic/oxidative stress and DNA damage in AD may activate PARP-1 in PBMCs similarly to CNS cells; PARP-1 activation in these cells could reflect systemic oxidative/DNA-damage signaling rather than direct neuronal-type pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Clinical peripheral blood samples (PBMCs) from AD patients cited; these are referenced observations rather than data produced in the present genotyping study.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>unspecified in the citations noted (general AD patients vs controls).</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>This paper does not report contradictory data; presence of PARP-1 activation in PBMCs is presented as an observed association in cited studies.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e180.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e180.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Lymphocytes</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Peripheral blood lymphocytes</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Circulating lymphocytes from AD patients cited in connection with oxidative DNA damage and levels of apoptotic proteins, linked by reference to polymorphism studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Evaluation of the Poly(ADP-ribose) Polymerase-1 Gene Variants in Alzheimer's Disease</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>lymphocytes</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>unclear</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Referenced study (ref. 30) reports associations between CHRNA4 polymorphisms and oxidative DNA damage and altered levels of apoptotic proteins in lymphocytes from AD patients, implying lymphocyte molecular changes but not explicit classification as susceptible/resilient to AD pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Genetic polymorphisms (e.g., in CHRNA4) and oxidative stress-related DNA damage leading to altered apoptotic protein levels; possible PARP-1-related responses to DNA strand breaks are discussed in the broader context of the paper.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Clinical samples: lymphocytes from AD patients (cited study), not generated by the present genotyping experiments.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>unspecified.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>No contradictory findings about lymphocyte status are presented in this paper.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease <em>(Rating: 2)</em></li>
                <li>Effect of amyloid beta peptide on poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus <em>(Rating: 2)</em></li>
                <li>Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress <em>(Rating: 1)</em></li>
                <li>Novel systemic markers for patients with Alzheimer disease?—a pilot study <em>(Rating: 1)</em></li>
                <li>Polymorphisms of the CHRNA4 gene encoding the alpha4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer's disease <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>